Library

2-aminoindāns

2-Aminoindane is a synthetic stimulant of the aminoindane class and a rigid structural analogue of amphetamine in which the propane chain is cyclized back onto the benzene ring. It first appeared on the research chemical market around 2003 and has been sold as a designer drug. Its effects have been compared to those of benzylpiperazine and methamphetamine, though very little is known about its recreational use profile.

Classification

  • Chemical: Aminoindane
  • Psychoactive: Stimulant

Effects

  • Stimulation
  • Pain Relief
  • Increased Heart Rate
  • Nausea
  • Temporary Erectile Dysfunction
  • Increased Perspiration
  • Focus Enhancement
  • Thought Acceleration
  • Analysis Enhancement
  • Wakefulness
  • Memory Enhancement
  • Motivation Enhancement
  • Dehydration
  • Appetite Suppression
  • Acuity Enhancement
  • Visual Acuity Enhancement
  • Increased Music Appreciation
  • Light Sensitivity

Routes of Administration

Oral

Dosage

  • Heavy: 40 mg
  • Light: 5 – 10 mg
  • Common: 10 – 20 mg
  • Strong: 20 – 40 mg
  • Threshold: 3 mg

Duration

  • Onset: 0.17-0.5 h
  • After Effects: 2-4 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

2-Aminoindane - DrugsPRO vielu ceļvedis

2-Aminoindane: 2-Aminoindane is a synthetic stimulant of the aminoindane class and a rigid structural analogue of amphetamine in which the propane chain is cyclized back onto the benzene ring. It first appeared on the research chemical market around 2003 and has been sold as a designer drug. Its eff

Related pages